Click for best price
Insomnia Therapy Market Size, Share 2024
| Market size in 2023 |
US$ 2735.2 million
|
Forecast Market size by 2030 |
US$ 3973.8 million
|
| Growth Rate |
CAGR of 5.5% |
Number of Pages |
129 Pages |
The global Insomnia Therapy market was valued at US$ 2735.2 million in 2023 and is projected to reach US$ 3973.8 million by 2030, at a CAGR of 5.5% during the forecast period.
The USA market for Global Insomnia Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Insomnia Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Insomnia Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Insomnia Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Insomnia Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Insomnia Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Insomnia Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Insomnia Therapy market presents opportunities for various stakeholders, including Hospital Pharmacies, Retail Pharmacies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Insomnia Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Key Features:
The research report on the Insomnia Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Insomnia Therapy market.
Market Overview: The report provides a comprehensive overview of the Insomnia Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-pharmacological Therapy, Pharmacological Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Insomnia Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Insomnia Therapy market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Insomnia Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Insomnia Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Insomnia Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Insomnia Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Insomnia Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Insomnia Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Insomnia Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Non-pharmacological Therapy
- Pharmacological Therapy
Market segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Insomnia Therapy Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Merck & Co.
- Sanofi
- Pfizer
- Takeda Pharmaceutical Company Ltd.
- Purdue Pharmaceuticals L.P.
- Eisai, Co. Ltd.
- Meda Consumer Healthcare
- Pernix Therapeutics
- Vanda Pharmaceuticals
- ECR Pharmaceuticals
- Fidia Farmaceutici
- Dainippon Sumitomo
- Biocodex
- Eli Lilly and Company
- Ebb Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insomnia Therapy, market overview.
Chapter 2: Global Insomnia Therapy market size in revenue.
Chapter 3: Detailed analysis of Insomnia Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insomnia Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Insomnia Therapy Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2735.2 million
|
| Forecast Market size by 2030 |
US$ 3973.8 million
|
| Growth Rate |
CAGR of 5.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
129 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapy Overall Market Size
2.1 Global Insomnia Therapy Market Size: 2023 VS 2030
2.2 Global Insomnia Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapy Players in Global Market
3.2 Top Global Insomnia Therapy Companies Ranked by Revenue
3.3 Global Insomnia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Insomnia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapy Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Therapy Market Size Markets, 2023 & 2030
4.1.2 Non-pharmacological Therapy
4.1.3 Pharmacological Therapy
4.2 By Type - Global Insomnia Therapy Revenue & Forecasts
4.2.1 By Type - Global Insomnia Therapy Revenue, 2019-2024
4.2.2 By Type - Global Insomnia Therapy Revenue, 2025-2030
4.2.3 By Type - Global Insomnia Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Therapy Market Size, 2023 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Insomnia Therapy Revenue & Forecasts
5.2.1 By Application - Global Insomnia Therapy Revenue, 2019-2024
5.2.2 By Application - Global Insomnia Therapy Revenue, 2025-2030
5.2.3 By Application - Global Insomnia Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Insomnia Therapy Market Size, 2023 & 2030
6.2 By Region - Global Insomnia Therapy Revenue & Forecasts
6.2.1 By Region - Global Insomnia Therapy Revenue, 2019-2024
6.2.2 By Region - Global Insomnia Therapy Revenue, 2025-2030
6.2.3 By Region - Global Insomnia Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Insomnia Therapy Revenue, 2019-2030
6.3.2 US Insomnia Therapy Market Size, 2019-2030
6.3.3 Canada Insomnia Therapy Market Size, 2019-2030
6.3.4 Mexico Insomnia Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Insomnia Therapy Revenue, 2019-2030
6.4.2 Germany Insomnia Therapy Market Size, 2019-2030
6.4.3 France Insomnia Therapy Market Size, 2019-2030
6.4.4 U.K. Insomnia Therapy Market Size, 2019-2030
6.4.5 Italy Insomnia Therapy Market Size, 2019-2030
6.4.6 Russia Insomnia Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Insomnia Therapy Market Size, 2019-2030
6.4.8 Benelux Insomnia Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Insomnia Therapy Revenue, 2019-2030
6.5.2 China Insomnia Therapy Market Size, 2019-2030
6.5.3 Japan Insomnia Therapy Market Size, 2019-2030
6.5.4 South Korea Insomnia Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Insomnia Therapy Market Size, 2019-2030
6.5.6 India Insomnia Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Insomnia Therapy Revenue, 2019-2030
6.6.2 Brazil Insomnia Therapy Market Size, 2019-2030
6.6.3 Argentina Insomnia Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Therapy Revenue, 2019-2030
6.7.2 Turkey Insomnia Therapy Market Size, 2019-2030
6.7.3 Israel Insomnia Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Insomnia Therapy Market Size, 2019-2030
6.7.5 UAE Insomnia Therapy Market Size, 2019-2030
7 Insomnia Therapy Companies Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Company Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Insomnia Therapy Major Product Offerings
7.1.4 Merck & Co. Insomnia Therapy Revenue in Global Market (2019-2024)
7.1.5 Merck & Co. Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Insomnia Therapy Major Product Offerings
7.2.4 Sanofi Insomnia Therapy Revenue in Global Market (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Therapy Major Product Offerings
7.3.4 Pfizer Insomnia Therapy Revenue in Global Market (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Company Summary
7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Major Product Offerings
7.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in Global Market (2019-2024)
7.4.5 Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Company Summary
7.5.2 Purdue Pharmaceuticals L.P. Business Overview
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Major Product Offerings
7.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in Global Market (2019-2024)
7.5.5 Purdue Pharmaceuticals L.P. Key News & Latest Developments
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Company Summary
7.6.2 Eisai, Co. Ltd. Business Overview
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Major Product Offerings
7.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue in Global Market (2019-2024)
7.6.5 Eisai, Co. Ltd. Key News & Latest Developments
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Company Summary
7.7.2 Meda Consumer Healthcare Business Overview
7.7.3 Meda Consumer Healthcare Insomnia Therapy Major Product Offerings
7.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue in Global Market (2019-2024)
7.7.5 Meda Consumer Healthcare Key News & Latest Developments
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Company Summary
7.8.2 Pernix Therapeutics Business Overview
7.8.3 Pernix Therapeutics Insomnia Therapy Major Product Offerings
7.8.4 Pernix Therapeutics Insomnia Therapy Revenue in Global Market (2019-2024)
7.8.5 Pernix Therapeutics Key News & Latest Developments
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Company Summary
7.9.2 Vanda Pharmaceuticals Business Overview
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Major Product Offerings
7.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue in Global Market (2019-2024)
7.9.5 Vanda Pharmaceuticals Key News & Latest Developments
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Company Summary
7.10.2 ECR Pharmaceuticals Business Overview
7.10.3 ECR Pharmaceuticals Insomnia Therapy Major Product Offerings
7.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue in Global Market (2019-2024)
7.10.5 ECR Pharmaceuticals Key News & Latest Developments
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Company Summary
7.11.2 Fidia Farmaceutici Business Overview
7.11.3 Fidia Farmaceutici Insomnia Therapy Major Product Offerings
7.11.4 Fidia Farmaceutici Insomnia Therapy Revenue in Global Market (2019-2024)
7.11.5 Fidia Farmaceutici Key News & Latest Developments
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Company Summary
7.12.2 Dainippon Sumitomo Business Overview
7.12.3 Dainippon Sumitomo Insomnia Therapy Major Product Offerings
7.12.4 Dainippon Sumitomo Insomnia Therapy Revenue in Global Market (2019-2024)
7.12.5 Dainippon Sumitomo Key News & Latest Developments
7.13 Biocodex
7.13.1 Biocodex Company Summary
7.13.2 Biocodex Business Overview
7.13.3 Biocodex Insomnia Therapy Major Product Offerings
7.13.4 Biocodex Insomnia Therapy Revenue in Global Market (2019-2024)
7.13.5 Biocodex Key News & Latest Developments
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Company Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Insomnia Therapy Major Product Offerings
7.14.4 Eli Lilly and Company Insomnia Therapy Revenue in Global Market (2019-2024)
7.14.5 Eli Lilly and Company Key News & Latest Developments
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Company Summary
7.15.2 Ebb Therapeutics Business Overview
7.15.3 Ebb Therapeutics Insomnia Therapy Major Product Offerings
7.15.4 Ebb Therapeutics Insomnia Therapy Revenue in Global Market (2019-2024)
7.15.5 Ebb Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Insomnia Therapy Market Opportunities & Trends in Global Market
Table 2. Insomnia Therapy Market Drivers in Global Market
Table 3. Insomnia Therapy Market Restraints in Global Market
Table 4. Key Players of Insomnia Therapy in Global Market
Table 5. Top Insomnia Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Insomnia Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Insomnia Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Insomnia Therapy Product Type
Table 9. List of Global Tier 1 Insomnia Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Insomnia Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Insomnia Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Insomnia Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Merck & Co. Company Summary
Table 31. Merck & Co. Insomnia Therapy Product Offerings
Table 32. Merck & Co. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Merck & Co. Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Insomnia Therapy Product Offerings
Table 36. Sanofi Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Sanofi Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Insomnia Therapy Product Offerings
Table 40. Pfizer Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer Key News & Latest Developments
Table 42. Takeda Pharmaceutical Company Ltd. Company Summary
Table 43. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Offerings
Table 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
Table 46. Purdue Pharmaceuticals L.P. Company Summary
Table 47. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Offerings
Table 48. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Purdue Pharmaceuticals L.P. Key News & Latest Developments
Table 50. Eisai, Co. Ltd. Company Summary
Table 51. Eisai, Co. Ltd. Insomnia Therapy Product Offerings
Table 52. Eisai, Co. Ltd. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Eisai, Co. Ltd. Key News & Latest Developments
Table 54. Meda Consumer Healthcare Company Summary
Table 55. Meda Consumer Healthcare Insomnia Therapy Product Offerings
Table 56. Meda Consumer Healthcare Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Meda Consumer Healthcare Key News & Latest Developments
Table 58. Pernix Therapeutics Company Summary
Table 59. Pernix Therapeutics Insomnia Therapy Product Offerings
Table 60. Pernix Therapeutics Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Pernix Therapeutics Key News & Latest Developments
Table 62. Vanda Pharmaceuticals Company Summary
Table 63. Vanda Pharmaceuticals Insomnia Therapy Product Offerings
Table 64. Vanda Pharmaceuticals Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Vanda Pharmaceuticals Key News & Latest Developments
Table 66. ECR Pharmaceuticals Company Summary
Table 67. ECR Pharmaceuticals Insomnia Therapy Product Offerings
Table 68. ECR Pharmaceuticals Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. ECR Pharmaceuticals Key News & Latest Developments
Table 70. Fidia Farmaceutici Company Summary
Table 71. Fidia Farmaceutici Insomnia Therapy Product Offerings
Table 72. Fidia Farmaceutici Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Fidia Farmaceutici Key News & Latest Developments
Table 74. Dainippon Sumitomo Company Summary
Table 75. Dainippon Sumitomo Insomnia Therapy Product Offerings
Table 76. Dainippon Sumitomo Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Dainippon Sumitomo Key News & Latest Developments
Table 78. Biocodex Company Summary
Table 79. Biocodex Insomnia Therapy Product Offerings
Table 80. Biocodex Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Biocodex Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Insomnia Therapy Product Offerings
Table 84. Eli Lilly and Company Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Ebb Therapeutics Company Summary
Table 87. Ebb Therapeutics Insomnia Therapy Product Offerings
Table 88. Ebb Therapeutics Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 89. Ebb Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Insomnia Therapy Segment by Type in 2023
Figure 2. Insomnia Therapy Segment by Application in 2023
Figure 3. Global Insomnia Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Insomnia Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Insomnia Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Therapy Revenue in 2023
Figure 8. By Type - Global Insomnia Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Insomnia Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Insomnia Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Insomnia Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Insomnia Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Insomnia Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Insomnia Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Insomnia Therapy Revenue Market Share, 2019-2030
Figure 16. US Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Insomnia Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Insomnia Therapy Revenue Market Share, 2019-2030
Figure 28. China Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Insomnia Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Insomnia Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Insomnia Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Merck & Co. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sanofi Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Eisai, Co. Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Meda Consumer Healthcare Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pernix Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Vanda Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. ECR Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Fidia Farmaceutici Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Dainippon Sumitomo Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Biocodex Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Eli Lilly and Company Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Ebb Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
